<DOC>
	<DOCNO>NCT01037712</DOCNO>
	<brief_summary>The infection cytomegalovirus ( CMV ) first cause congenital neurological handicap infectious origin . It probable neonatal viral load correlate become infect new-born baby . Among active antiviral treatment CMV , valacyclovir whose fetal maternal tolerance evaluate pregnancy . Its harmlessness aptitude decrease CMV viral load justify evaluate study placebo . Decrease fetal viral load could make possible decrease symptomatology neonatal group infect fetus .</brief_summary>
	<brief_title>In UTERO Treatment Cytomegalovirus Congenital Infection With Valacyclovir</brief_title>
	<detailed_description>The infection cytomegalovirus ( CMV ) first cause congenital neurological handicap infectious origin . It probable neonatal viral load correlate become infect new-born baby . Among active antiviral treatment CMV , valacyclovir whose fetal maternal tolerance evaluate pregnancy . Its harmlessness aptitude decrease CMV viral load justify evaluate study placebo . Decrease fetal viral load could make possible decrease symptomatology neonatal group infect fetus . To evaluate effect treatment valacyclovir inject per bone mother case prove fetal infection CMV ( positive PCR CMV amniotic liquid ) present cerebral extra echographic sign able allotted infection . The main objective observe treat group , reduction number unfavourable exit ( symptomatic child birth ) reduction number medical interruption pregnancy practise fetal anomaly . The secondary objective reduction treat group , CMV viral load blood cord take birth . The attribution treatment carry draw lot , accord procedure double blind establish diagnosis fetal infection . In absence reference treatment , placebo employ reference group . The patient include thus place one 2 parallel group . The observance evaluate . Taking consideration preliminary study , difference 20 % 2 group discount . The number calculated subject include test order guarantee power 80 % 82 group . Recruitment carry multicentric way . The necessary duration inclusion 36 month The comparison two treatment carry composite principal criterion accord : proportion pregnancy unfavourable exit ( symptomatic child birth medical interruption pregnancy practise appeared cerebral echographic anomaly connection fetal infection CMV ) . The secondary criterion judgement : viral load blood cord newborns infect UTERO CMV , compliance criterion tolerance .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Age ≥ 18 year , Fetal Infection CMV authenticate positivity research viral genome PCR amniotic liquid , Echographic Assessment reveal least one cerebral extra anomaly able connection infection CMV , Absence request termination pregnancy start , Acceptance strict followup Multifield Center Prenatal diagnosis optimal observance found treatment , Collection write assent take part test . Affiliation mode social security equivalent No affiliation mode social security ( profit right ) Patient le 18 year , Patient present another pathology obstetrical medical ( particular hepatic renal ) preexistent track contraindicate use valacyclovir , Patients whose fetus present echographic sign able connection infection CMV , Patients whose fetus present least one cerebral echographic anomaly : IntraparenchymalVentriculomegaly measure ventricular crossroad ≥ 12mm Hyperechogenicity periventricular Hydrocephaly Intraventricular adherence Microcephaly Increase cut large retrocerebellar cistern Hypoplasia vermis Intraparenchymal calcification Porencephaly Lissencephaly Cysts periventricular Hypoplasia callous body Signs LENTICULOstriated vasculopathy Patient active antiviral treatment CMV , Patient take part another therapeutic test , Patient refuse sign enlighten assent , Patient formulate request medical interruption pregnancy inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Foetuses infection CMV</keyword>
	<keyword>neurological handicap infectious origin .</keyword>
</DOC>